Shanghai Hile Bio-Technology Co Ltd Class A 603718
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 8.10
- Day Range
- CNY 7.87–8.13
- 52-Week Range
- CNY 6.00–11.87
- Bid/Ask
- CNY 7.93 / CNY 7.94
- Market Cap
- CNY 5.22 Bil
- Volume/Avg
- 4.3 Mil / 6.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- 534.34
- Price/Sales
- 20.78
- Dividend Yield (Trailing)
- 0.71%
- Dividend Yield (Forward)
- 0.71%
- Total Yield
- 0.70%
Company Profile
Shanghai Hile Bio-Technology Co Ltd is a veterinary biological product manufacturer integrating research and development, production, sales, and service. The company has over 40 categories of poultry, livestock, and pets. The company provides services for the prevention of livestock diseases, improving the health of livestock and poultry, and improving the production efficiency of farmers, and is able to provide comprehensive solutions and an authoritative veterinary expert service system.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 295
- Website
- http://www.hile-bio.com
Comparables
Valuation
|
Metric
|
603718
|
600201
|
300119
|
|---|---|---|---|
Price/Earnings (Normalized) | 534.34 | 36.97 | 21.47 |
Price/Book Value | 4.36 | 2.17 | 1.73 |
Price/Sales | 20.78 | 7.45 | 3.35 |
Price/Cash Flow | 191.76 | 23.76 | 17.90 |
Price/Earnings
603718
600201
300119
Financial Strength
|
Metric
|
603718
|
600201
|
300119
|
|---|---|---|---|
Quick Ratio | 1.12 | — | — |
Current Ratio | 1.39 | — | — |
Interest Coverage | 6.48 | — | — |
Quick Ratio
603718
600201
300119
Profitability
|
Metric
|
603718
|
600201
|
300119
|
|---|---|---|---|
Return on Assets (Normalized) | 0.58% | 3.70% | 5.24% |
Return on Equity (Normalized) | 0.78% | 4.70% | 7.54% |
Return on Invested Capital (Normalized) | 1.01% | 3.59% | 6.35% |
Return on Assets
603718
600201
300119
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Cqvktqhw | Vqqh | $586.3 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Zqwwchw | Lvmpkvb | $115.1 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Qpzcwbnfr | Tncnmr | $108.2 Bil | |
MRNA
| Moderna Inc | Vjnvbjf | Dlyzv | $54.0 Bil | |
BNTX
| BioNTech SE ADR | Wzxbdbyx | Hljm | $21.8 Bil | |
ARGX
| argenx SE ADR | Slzgystm | Vqnc | $21.6 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Whbrqtkw | Zvgjt | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Sxmgjlctl | Qhddxs | $14.6 Bil | |
INCY
| Incyte Corp | Xbhzlll | Vysbqt | $12.9 Bil | |
RPRX
| Royalty Pharma PLC Class A | Htwjsqsb | Bfwcvqq | $12.3 Bil |